Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Many patients use fish oil in the hope of relief from inflammatory conditions or to reduce risks of cardiovascular disease. As non-prescription complementary medicines, it is likely many patients are not abreast of how to use fish oil in...
How pharmacists can change the lives of people with lung diseases by taking every opportunity possible.
Wherever pharmacists practise, there are patients with anxiety – patients who are managing well, patients who are managing not so well, and patients in crisis.
Early initiation of an antibiotic for a COPD flare-up can prevent further damage to the airways, prevent hospitalisation, reduce the risk of further exacerbations, and allow people to regain symptom control.
A new standard of care will help to prevent long-term reliance on opioid analgesics used for acute pain.
New regulations and building back immunity to influenza are key to protecting the community this season and avoiding 'flurona'.
After 2 years of low influenza rates due to COVID-19, the 2022 flu season is unpredictable, and could be a whopper. Here are six things you need to know.
Pharmacists can be important allies for the hundreds of thousands of ‘endo warriors’ across the country.
Two pharmacists share safety risks averted by using every DAA packing check as a mini-medicine review.
The Therapeutic Goods Administration (TGA) has provisionally approved two oral antiviral treatments for COVID-19. Here’s what pharmacists need to know.
